---

---

 

Summit Partners Public Asset Management, LLC (“SPPAM”), the investment manager with respect to the shares directly held by Summit Partners Concentrated Growth L/S Master Fund, L.P. (the “Fund”). SPPAM is a Delaware limited liability company located at 222 Berkeley Street, 18th Floor, Boston, MA 02116.

Summit Partners, L.P. (“SP”), the Managing Member of SPPAM, with respect to the shares directly held by the Fund. SP is a Delaware limited partnership located at 222 Berkeley Street, 18th Floor, Boston, MA 02116.

Summit Partners Concentrated Growth L/S Master Fund, L.P., a Cayman Islands limited partnership, with respect to the shares directly owned by it. The Fund’s registered office is c/o Walker Corporate Limited, Cayman Corporate Centre, 27 Hospital Road, George Town, Grand Cayman KY1-9008, Cayman Islands.

Summit Partners Alydar GP, L.P. (“Fund GP”), the general partner of the Fund with respect to the shares directly held by the Fund. Fund GP is a Delaware limited partnership located at 222 Berkeley Street, 18th Floor, Boston, MA 02116.

Summit Partners Alydar GP, LLC (“GP”), the general partner of Fund GP with respect to the shares directly held by the Fund. GP is a Delaware limited liability company located at 222 Berkeley Street, 18th Floor, Boston, MA 02116.

Philip Furse, the Chief Investment Officer of SPPAM and a Portfolio Manager of the Fund with respect to the shares directly held by the Fund. Mr. Furse is a United States Citizen with a business address at 222 Berkeley Street, 18th Floor, Boston, MA 02116.

Timothy Albright, a Portfolio Manager of SPPAM with respect to the shares directly held by the Fund. Mr. Albright is a United States Citizen with a business address at 222 Berkeley Street, 18th Floor, Boston, MA 02116.

Robert MacAulay, the Chief Risk Officer of SPPAM with respect to the shares directly held by the Fund. Mr. MacAulay is a United States Citizen with a business address at 222 Berkeley Street, 18th Floor, Boston, MA 02116.

 

The foregoing persons are hereinafter sometimes collectively referred to as the "Reporting Persons."

 

Item 2.

(d) Title of Class of Securities

Class A Common Stock, par value $.0001 per share (the “Common Stock”)

 

Item 2.

(e) CUSIP No.:

05988J103

Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

	(a)	¨	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
	(b)	¨	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
	(c)	¨	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
	(d)	¨	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
	(e)	o	An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
	(f)	¨	An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
	(g)	¨	A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);
	(h)	¨	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
	(i)	¨	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
	(j)	¨	A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J);
	(k)	¨	A group, in accordance with §240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution:

Information with respect to the Reporting Persons' ownership of the Common Stock as of July 2, 2018 is incorporated by reference to items (5) - (9) and (11) of the cover page of the respective Reporting Person.

The percentage of beneficial ownership is determined by dividing the number of shares of Common Stock beneficially owned by the Reporting Persons, 212,869, by 4,207,908, the number of shares of Common Stock issued and outstanding as of April 30, 2018, as the Issuer reported in its Form 10-Q for the quarterly period ended March 31, 2018 filed with the SEC on May 5, 2018.

By virtue of the affiliate relationships among the Reporting Persons and by virtue of Mr. Furse being the Chief Investment Officer of SPPAM and a Portfolio Manager of the Fund, Mr. Albright being a Portfolio Manager of SPPAM and Mr. MacAulay being the Chief Risk Officer of SPPAM, each Reporting Person may be deemed to own beneficially all of the 212,869 shares of Common Stock as of July 2, 2018. Each of the Reporting Persons expressly disclaims beneficial ownership of any shares of Common Stock, except for the Fund with respect to the shares and warrants held of record by it and except to the extent of its pecuniary interest therein.

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 

 

CUSIP No. 05988J103

SCHEDULE 13G

Page 13 of 14 Pages

 

 

SIGNATURE

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Dated: July 2, 2018

 

 

 

	Summit Partners Public Asset Management, LLC
	By:	/s/ Robin W. Devereux
		Robin W. Devereux, Chief Compliance Officer

	Summit Partners, L.P.
	By:	/s/ Robin W. Devereux
		Robin W. Devereux, Authorized Person

	Summit Partners Concentrated Growth L/S Master Fund, L.P. By:  Summit Partners Alydar GP, L.P., its general partner
	By:	/s/ Robin W. Devereux
		Robin W. Devereux, Authorized Person

	Summit Partners Alydar GP, L.P.
	By:	/s/ Robin W. Devereux
		Robin W. Devereux, Authorized Person

	Summit Partners Alydar GP, LLC
	By:	/s/ Robin W. Devereux
		Robin W. Devereux, Authorized Person

	Philip C. Furse
	By:	/s/ Robin W. Devereux
		Robin W. Devereux, POA for Philip C. Furse

	Timothy K. Albright
	By:	/s/ Robin W. Devereux
		Robin W. Devereux, POA for Timothy K. Albright

	Robert E. MacAulay
	By:	/s/ Robin W. Devereux
		Robin W. Devereux, POA for Robert E. MacAulay

 

CUSIP No. 05988J103

SCHEDULE 13G

Page 14 of 14 Pages

 

Exhibit I

 

JOINT FILING STATEMENT

 

PURSUANT TO RULE 13d-1(k)

 

The undersigned acknowledge and agree that the foregoing statement on Schedule 13G, is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G, shall be filed on behalf of each of the undersigned without the necessity of filing additional joint acquisition statements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate.

 

Dated: July 2, 2018

 

	Summit Partners Public Asset Management, LLC
	By:	/s/ Robin W. Devereux
		Robin W. Devereux, Chief Compliance Officer

	Summit Partners, L.P.
	By:	/s/ Robin W. Devereux
		Robin W. Devereux, Authorized Person

	Summit Partners Concentrated Growth L/S Master Fund, L.P. By:  Summit Partners Alydar GP, L.P., its general partner
	By:	/s/ Robin W. Devereux
		Robin W. Devereux, Authorized Person

	Summit Partners Alydar GP, L.P.
	By:	/s/ Robin W. Devereux
		Robin W. Devereux, Authorized Person

	Summit Partners Alydar GP, LLC
	By:	/s/ Robin W. Devereux
		Robin W. Devereux, Authorized Person

       

	Philip C. Furse
	By:	/s/ Robin W. Devereux
		Robin W. Devereux, POA for Philip C. Furse

	Timothy K. Albright
	By:	/s/ Robin W. Devereux
		Robin W. Devereux, POA for Timothy K. Albright

	Robert E. MacAulay
	By:	/s/ Robin W. Devereux
		Robin W. Devereux, POA for Robert E. MacAulay